3-Chloro-N′-(2-hydroxybenzylidene) benzohydrazide: An LSD1-Selective Inhibitor and Iron-Chelating Agent for Anticancer Therapy

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Federica Sarno, Chiara Papulino, Gianluigi Franci, Jeanette H. Andersen, Bastien Cautain, Colombina Melardo, Lucia Altucci, Angela Nebbioso

Journal title: Frontiers in Pharmacology

Journal number: 9

Journal publisher: Frontiers Media S.A.

Published year: 2018

DOI identifier: 10.3389/fphar.2018.01006

ISSN: 1663-9812